|
Uncover bias in clinical trials
Gale Pearson
Clinical trials of pharmaceutical products are crucial to understanding a drug’s efficacy and side effects. But even the most seemingly well-designed studies can have hidden biases—especially studies funded by drug manufacturers. Learn how to check for the most common research shortcomings that point to flawed methodology and a tendency to downplay the drug’s dangers.
Don’t know much about epidemiology
Steven Rotman
Proving causation can make or break a drug product case. But the line from cause to disease—for instance, from tobacco to lung cancer—is not always a straight one. To build your case on a foundation of reliable medical literature, you need to get a firm grasp of epidemiological principles and be ready to parry defense counsel’s negative spin on your evidence with solid and well-presented facts.
Ghostwriters and ghostbusters
Jerome P. Kassirer
Too often, the doctor whose byline appears on a published medical study, review article, or editorial didn’t write it. Instead, someone working for a pharmaceutical company did the writing, and the doctor was paid to sign his or her name to it. Ghostwriting corrupts the standards and integrity of science and the medical literature and can have serious real-life consequences. Here’s what’s being done to root out this unethical practice.
Nonparty discovery in drug cases
James F. Szaller and Jeff Gibson
Drug manufacturers frequently rely on public-relations, marketing,
and advertising companies, as well as trade associations, to
make sure their new product gets glowing reviews and kid-glove
treatment in the press, and to tamp down information about its
risks. Employees of these firms may be privy to data and documents
the drug company would prefer to keep hidden. Learn to identify
and question the promoters to make your discovery efforts pay off.
|
Features
AAJ officers, 2007-2008
Meet the new president, president-elect, vice president, treasurer, secretary, and parliamentarian for the upcoming year. These newly elected leaders talk about AAJ’s past victories, current projects, and hopes for the future, sharing their vision of how AAJ will continue fighting for the rights of all Americans.
Twists at trial
You may be perfectly prepared for trial, but a sudden twist can still catch you off guard. Maybe a witness freezes up, a document gets lost, or an expert gets waylaid: Anything can happen. Sometimes you can turn that twist of fate to your advantage. Read about four lawyers who did just that and won their cases despite having to make an unexpected detour.
|
News & Trends
No-preemption ruling spurs Zyprexa cases forward
D.C. court reverses itself: awards for nonphysical injury may be taxed
AMA outlines plans for “health courts”
Learned-intermediary doctrine rejected in West Virginia
Student’s IM threat is not protected speech, Second Circuit says
Court OKs case against debt collectors for “outrageous” threats
Departments
President’s page
Honor is due
Supreme Court review
The Court deals a blow to pay discrimination plaintiffs
Letters
Hearsay
Justice in motion
‘Health court’ proposals would burden taxpayers, limit rights
Presidential candidates at convention join call for strong civil justice system
New litigation groups lead efforts in emerging areas
AAJ supplies full-scale assistance for facing big pharma
Straight talk about vaccines
Books
Undermining Science: Suppression and Distortion in the Bush Administration by Seth Shulman
Supreme Conflict: The Inside Story of the Struggle for Control of the United States Supreme Court by Jan Crawford Greenburg
Experts & Professional Services
Classifieds
Lawyer Networking
Products & Services
|
